Skip to content

Clinical trials

Observational Prostatic Neoplasms trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Neoplasms Phase: Observational Country / region: Australia Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20071
20111
20121
20131
20171
20192
20211
20231
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting4
Active, not recruiting1
Not yet recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Astellas Pharma Global Development, Inc.1
AstraZeneca1
Barwon Health1
Calvary Mater Newcastle, Australia1
European Organisation for Research and Treatment of Cancer - EORTC1
Janssen Research & Development, LLC1
Melbourne Health1
Peter MacCallum Cancer Centre, Australia1
Prostate Cancer Clinical Trials Consortium1
Trans Tasman Radiation Oncology Group1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Neoplasms12
Brain Neoplasms2
Breast Neoplasms2
Head and Neck Neoplasms2
Liver Neoplasms2
Pancreatic Neoplasms2
Anus Neoplasms1
Arrhythmias, Cardiac1
Carcinoma, Hepatocellular1
Esophageal Neoplasms1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.